Paul Surdez has led award-winning investor relations programs at public healthcare companies, including multiple S&P 500 companies, since 2002. He has been recognized numerous times in buy-side and sell-side surveys as a top investor relations officer during his tenures at Catalent, LabCorp, and Covance.
Paul received both his MBA and B.S. from Rutgers Business School, where he volunteers as a guest speaker and investor relations subject matter expert. He earned the Investor Relations Charter (IRC) credential awarded by the National Investor Relations Institute (NIRI) in 2017.
